ArticleFrontiers in oncology2023

EGFR p.V774M/p.L833V compound mutations in lung adenocarcinoma responded well to almonertinib: a case report.

Hai Pan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.